Abstract 4371326: Novel Role of Copper Transporter CTR1 in VEGF-C-induced VEGFR3 Signaling and Lymphangiogenesis

Background: VEGF-C is a central regulator of lymphangiogenesis, the formation of new lymphatic vessels, by binding to VEGFR-3 on lymphatic endothelial cels (LECs), triggering signaling pathways promoting their migration, and forming new lymphatic vessels. While we reported that reactive oxygen species (ROS) from NADPH oxidases (NOXs) and mitochondria, as well as physiological copper (Cu) levels regulated by the Cu uptake transporter CTR1, are important in angiogenesis, their roles in VEGF-C-induced VEGFR3 signaling and lymphangiogenesis remain unknown. Results: Here we show that VEGF-C stimulation induced a biphasic ROS response in human LECs, an early transient increase within 30 min and a sustained late-phase elevation up to 4 hrs. Overexpression of mitochondria-targeted catalase (mito-catalase), but not NOX4 knockdown, suppressed both VEGF-C-induced ROS production and key lymphangiogenic responses including EC proliferation (1.9 fold), migration (2.5 fold), and tube formation (1.2 fold), indicating a predominant role for mitochondrial ROS (mitoROS). Mito-catalase also attenuated VEGFR3 phosphorylation and downstream ERK1/2 and Akt activation. We then examined the role of Cu and CTR1 and found that CTR1 knockdown significantly impaired VEGF-C-induced VEGFR3, ERK1/2, and Akt phosphorylation, late-phase ROS production, and lymphangiogenic responses without affecting early ROS generation. In contrast, Cu chelation with BCS inhibited late-phase ROS and lymphangiogenesis without affecting VEGFR3 activation, suggesting a Cu-independent role of CTR1 in initiating VEGFR3 signaling. Mechanistically, VEGF-C promoted rapid CTR1-VEGFR3 association and co-internalization within 30 min, supporting receptor activation and sustained ROS generation. In vivo, VEGF-C-induced lymphangiogenesis and inflammatory cell recruitment (Lyve1+, VEGFR3+, and CD45+ cells) were significantly diminished in Ctr1 +/- mice using a Matrigel plug model. Conclusion: These findings uncover a novel biphasic mechanism whereby VEGF-C promotes lymphangiogenesis through mitoROS-CTR1-VEGFR3 axis which initiates VEGFR3 signaling independent of Cu, followed by Cu-dependent ROS amplification to sustain downstream migration and tube formation. This study reveals CTR1 as a critical regulator of VEGFR3 signaling and lymphatic vessel formation.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-03
DOI
https://doi.org/10.1161/circ.152.suppl_3.4371326
Primary Topic
Lymphatic System and Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4371326: Novel Role of Copper Transporter CTR1 in VEGF-C-induced VEGFR3 Signaling and Lymphangiogenesis

Archita Das, Masuko Ushio‐Fukai, Tohru Fukai
Circulation
Lymphatic System and Diseases
article

Abstract 4371326: Novel Role of Copper Transporter CTR1 in VEGF-C-induced VEGFR3 Signaling and Lymphangiogenesis

Archita Das, Masuko Ushio‐Fukai, Tohru Fukai
article en

Abstract

Background: VEGF-C is a central regulator of lymphangiogenesis, the formation of new lymphatic vessels, by binding to VEGFR-3 on lymphatic endothelial cels (LECs), triggering signaling pathways promoting their migration, and forming new lymphatic vessels. While we reported that reactive oxygen species (ROS) from NADPH oxidases (NOXs) and mitochondria, as well as physiological copper (Cu) levels regulated by the Cu uptake transporter CTR1, are important in angiogenesis, their roles in VEGF-C-induced VEGFR3 signaling and lymphangiogenesis remain unknown. Results: Here we show that VEGF-C stimulation induced a biphasic ROS response in human LECs, an early transient increase within 30 min and a sustained late-phase elevation up to 4 hrs. Overexpression of mitochondria-targeted catalase (mito-catalase), but not NOX4 knockdown, suppressed both VEGF-C-induced ROS production and key lymphangiogenic responses including EC proliferation (1.9 fold), migration (2.5 fold), and tube formation (1.2 fold), indicating a predominant role for mitochondrial ROS (mitoROS). Mito-catalase also attenuated VEGFR3 phosphorylation and downstream ERK1/2 and Akt activation. We then examined the role of Cu and CTR1 and found that CTR1 knockdown significantly impaired VEGF-C-induced VEGFR3, ERK1/2, and Akt phosphorylation, late-phase ROS production, and lymphangiogenic responses without affecting early ROS generation. In contrast, Cu chelation with BCS inhibited late-phase ROS and lymphangiogenesis without affecting VEGFR3 activation, suggesting a Cu-independent role of CTR1 in initiating VEGFR3 signaling. Mechanistically, VEGF-C promoted rapid CTR1-VEGFR3 association and co-internalization within 30 min, supporting receptor activation and sustained ROS generation. In vivo, VEGF-C-induced lymphangiogenesis and inflammatory cell recruitment (Lyve1+, VEGFR3+, and CD45+ cells) were significantly diminished in Ctr1 +/- mice using a Matrigel plug model. Conclusion: These findings uncover a novel biphasic mechanism whereby VEGF-C promotes lymphangiogenesis through mitoROS-CTR1-VEGFR3 axis which initiates VEGFR3 signaling independent of Cu, followed by Cu-dependent ROS amplification to sustain downstream migration and tube formation. This study reveals CTR1 as a critical regulator of VEGFR3 signaling and lymphatic vessel formation.

CirculationVol. 152(Suppl_3)
Augusta University Health (US)
Openalex Percentile: Top 57%
Lymphatic System and Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.